Image Name

News

2023 Self-Monitoring Public Disclosure for Shangma Park

Date:

30 Dec,2023

 

Self-Monitoring Report for Shangma Park, 2023

For details of the year-round public disclosure, please refer to the attachment.

 

 

Previous page

2022 Self-Monitoring Public Disclosure for Shangma Park

Good News | Wanbangde Pharmaceutical Group’s Huperzine A for Treating Myasthenia Gravis Receives U.S. FDA Orphan Drug Designation!

Next page

Related Recommendations